In a bid to expand its position in the fast-growing diabetes market, Ahmedabad-based Eris Lifesciences on Tuesday said it has entered the race to commercialise semaglutide in India through a strategic ...

Synopsis: Generic medicines are cost-effective versions of patented drugs that meet identical safety and efficacy standards. India leads the global generics market due to scale, regulatory compliance, ...

Sales of weight loss medicines like Ozempic and Mounjaro have skyrocketed in South Africa in recent years. However, they remain too expensive for most people who might benefit from the jabs. Spotlight ...

Oral anti-obesity formulations will be the next growth lever in Danish drugmaker Novo Nordisk's India strategy, following the 2025 launches of its blockbuster diabetes and obesity brands Ozempic and ...